Nureca Limited (NURECA) — Insider Trading | 11 August 2026
Nureca Limited disclosed an insider share purchase by a designated person under SEBI PIT Regulations, Regulation 7(2), which was not automatically reflected on stock exchanges but manually reported to ensure compliance, with no resolution yet received from exchanges.
About Nureca Limited (NURECA)
Healthcare · Healthcare Equipment & Supplies · Listed on NSE
📡 Get AI alerts when NURECA files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track NURECA — Free💡 Ask AI about this filing
📊 More NURECA filings
- 🟡 Board Meeting — 21 July 2026 Nureca Limited announced the unaudited standalone and consolidated financial results for Q1 FY26-27 ...
- 🔴 Financial Results — 21 July 2026 Nureca reported Q1 FY27 revenue of **₹40.3 crores**, up 14% QoQ and 18% YoY, driven by strong gross ...
- share transfer — 15 July 2026 Nureca Limited received a SEBI-mandated share transfer agent certificate for the quarter ended June ...
- 🔴 Insider Trading — 3 July 2026 Mr. Aryan Goyal, a promoter group member of Nureca Limited, disposed of equity shares via an off-mar...
- 🔴 Annual Report — 3 July 2026 Nureca Limited's FY26 annual report shows revenue growth of 34% to ₹1,469.93 crores, EBITDA up 68.94...
🔥 Also filed on 11 August 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when NURECA files new disclosures
Track NURECA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track NURECA — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research